One of the classic effects of cannabis on people is raging hunger-the “marijuana munchies.” The drug has been used to good effect on people with diseases that diminish appetite, helping them to regain a healthy interest in food. So it is a bit ironic that British drug maker GW Pharmaceuticals has created a cross-bred cannabis plant whose appetite-suppressing qualities could be used to treat type 2 diabetes.

It’s a condition that affects millions of people in the UK, yet dozens of myths still surround diabetes.

An international study shows that diabetes worldwide has increased dramatically over the past three decades.

Predictors for type 2 diabetes are easily identifiable, according to a large community study undertaken to understand diabetes and the disease burden, and may lead to earlier intervention for people at risk.